Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Prolonging fixation time of an alternative fixative to formalin for dermatological samples using standard laboratory protocols

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Predictive value of AZGP1 following radical prostatectomy for prostate cancer: a cohort study and meta-analysis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Plasma levels of intact and cleaved urokinase plasminogen activator receptor (uPAR) in men with clinically localised prostate cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Prevalence of human papillomavirus in squamous cell carcinomas of the soft palate

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. ERG protein expression over time from diagnostic biopsies to radical prostatectomy specimens in clinically localised prostate cancer.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Significance of acquired diverticular disease of the vermiform appendix: a marker of regional neoplasms?

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Regional Differences in Neuroinflammation-Associated Gene Expression in the Brain of Sporadic Creutzfeldt-Jakob Disease Patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The molecular profile of mucosal melanoma

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

AIMS: Though formalin remains to be the gold standard fixative in pathology departments, analytical challenges persist for nucleic acid evaluations. In our laboratory, formalin fixation of skin samples in particular impairs diagnostic accuracy and demands repetition of biopsies and analytical procedures. PAXgene Tissue Systems may be an alternative; however, according to manufacturer specifications it only allows fixation for 48 hours before having to add a stabiliser. This may be a challenge in laboratories, which are closed in weekends and bank holidays. Our aim was to validate this alternative fixative for dermatological samples with prolonged fixation times using standard laboratory protocols developed for formalin-fixed specimens. We compared the results with gold standard formalin fixation.

METHODS: Skin specimens were formalin or PAXgene fixed for either 2 hours, 24 hours, 3 days or 7 days, paraffin-embedded, analysed and scored by observers.

RESULTS: Generally, formalin outperformed PAXgene fixation in H&E stains and fluorescence in situ hybridisation (FISH), but both seem usable for diagnostics. Time of PAXgene fixation did not have an impact on alcian blue-Van Gieson (ABVG), H&E (p=0.48), nor immunohistochemistry (p=0.74). There was a tendency towards best PAXgene performance at 24 hours of fixation for FISH, and for DNA integrity analysis 24 hours or 3 days.

CONCLUSIONS: Prolonging PAXgene fixation time to 3 days before adding stabiliser does not seem to have major impact on performance of general diagnostic analysis, but our preliminary results show optimisation of internal protocols are needed. PAXgene is an expensive alternative and may be confined to some dermatological samples.

Original languageEnglish
JournalJournal of Clinical Pathology
Volume74
Issue number3
Pages (from-to)149-156
Number of pages8
ISSN0021-9746
DOIs
Publication statusPublished - Mar 2021

    Research areas

  • diagnostic techniques and procedures, immunohistochemistry, medical laboratory science, molecular biology, skin

ID: 61923899